+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Hemophilia Treatment Market - Global Industry Analysis (2019 - 2021) - Growth Trends and Market Forecast (2022 - 2027) - Product Thumbnail Image

Hemophilia Treatment Market - Global Industry Analysis (2019 - 2021) - Growth Trends and Market Forecast (2022 - 2027)

  • Report
  • May 2022
  • 196 Pages
Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2022-2026) - Product Thumbnail Image

Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

  • Report
  • April 2022
  • 106 Pages
From
Hemophilia Treatment Market - Product Thumbnail Image

Hemophilia Treatment Market

  • Report
  • February 2022
  • 312 Pages
From
Hemophilia Market Analysis, By Type, By Product, By Treatment Type, By Therapy Type, Forecasts To 2027 - Product Thumbnail Image

Hemophilia Market Analysis, By Type, By Product, By Treatment Type, By Therapy Type, Forecasts To 2027

  • Report
  • July 2020
  • 157 Pages
From
Hemophilia Treatment Market Research Report by Product Type, Disease Indication, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Hemophilia Treatment Market Research Report by Product Type, Disease Indication, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • April 2022
  • 208 Pages
From
Hemophilia Treatment Market Research Report by Product Type, Disease Indication, Distribution, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Hemophilia Treatment Market Research Report by Product Type, Disease Indication, Distribution, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • April 2022
  • 118 Pages
From
Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023) - Product Thumbnail Image

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

  • Report
  • July 2019
  • 109 Pages
From
Global Rare Hemophilia Factors Market 2022-2026 - Product Thumbnail Image

Global Rare Hemophilia Factors Market 2022-2026

  • Report
  • June 2022
  • 120 Pages
From
Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region - Forecast to 2029 - Product Thumbnail Image

Hemophilia Market Analysis by Type (Type A, B, C,), by Treatment (Prophylaxis, On-Demand), by Therapy (Gene, Replacement, Immune Tolerance Induction (ITI) Therapy), and by Region - Forecast to 2029

  • Report
  • April 2022
  • 137 Pages
From
von Willebrand Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027 - Product Thumbnail Image

von Willebrand Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027

  • Report
  • July 2019
  • 241 Pages
From
Hemophilia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) - Product Thumbnail Image

Hemophilia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • Report
  • July 2021
  • 115 Pages
From
Blood and Plasma Components Market - A Global and Regional Analysis: Focus on Product, Application, End User and Region - Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Blood and Plasma Components Market - A Global and Regional Analysis: Focus on Product, Application, End User and Region - Analysis and Forecast, 2021-2031

  • Report
  • May 2022
  • 228 Pages
From
Hemophilia Market 2020-2026 - Product Thumbnail Image

Hemophilia Market 2020-2026

  • Report
  • August 2020
From
Von Willebrand Disease Treatment Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Von Willebrand Disease Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • June 2020
  • 111 Pages
From
Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product; Disease; Treatment Type; Therapy; End User, and Geography - Product Thumbnail Image

Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product; Disease; Treatment Type; Therapy; End User, and Geography

  • Report
  • February 2020
  • 225 Pages
From
Human Prothrombin Complex Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Human Prothrombin Complex Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Product Type

  • Report
  • May 2022
  • 83 Pages
From
Global Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Global Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • April 2021
  • 145 Pages
From
Global Von Willebrand Disease Treatment Market 2019-2023 - Product Thumbnail Image

Global Von Willebrand Disease Treatment Market 2019-2023

  • Report
  • November 2018
  • 115 Pages
From
Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021 - Product Thumbnail Image

Obsessive-Compulsive Disorder (Central Nervous System) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Europe Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Europe Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • April 2021
  • 68 Pages
From
Loading Indicator